Monday, 16 April 2012 09:10
‘The treatment, which uses viruses carrying human DNA to direct the body’s natural defences against cancer cells, is the first prostate cancer vaccine ever to reach late stage “phase three” trials in Europe.
No vaccines have yet been approved in Britain to treat any type of cancer, and scientists believe it could not only double the survival rate of prostate cancer sufferers but give way to a new range of similar treatments for other tumour types.’
Read more: Prostate Cancer Vaccine Contains Genetically Modified DNA
Related posts:
Clock ticking for KPN in battle vs. Carlos Slim
Israeli organ trade ring-leader nabbed
Barack Obama In Afghanistan To Sign Security Pact
Charlotte, N.C., Police Chaplains Told to Stop Praying in Jesus’ Name
Jerry Brown On California Budget Shortfall: 'We Will Have To Go Much Farther' With Cuts (VIDEO)
Syria: 15 troops killed in Aleppo